|
HS Code |
577936 |
| Cas Number | 73099-57-7 |
| Chemical Formula | C4H5BrN2 |
| Molecular Weight | 177.00 g/mol |
| Appearance | Off-white to light brown solid |
| Melting Point | 101-105 °C |
| Purity | Typically ≥ 97% |
| Synonyms | 5-Bromo-4-methylimidazole |
| Solubility In Water | Slightly soluble |
| Storage Conditions | Store at 2-8°C, tightly closed, dry |
| Smiles | CC1=CN=CN1Br |
As an accredited 4-Methyl-5-Bromoimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Methyl-5-Bromoimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In any laboratory or advanced manufacturing space, choosing the right chemical matters. I’ve come across my share of specialty reagents, but 4-Methyl-5-Bromoimidazole stands out for its practical value in synthetic chemistry. As someone with hands-on experience sourcing compounds for both research and pilot projects, the unique benefits of this molecule are clear the moment I open its datasheet and talk to chemists who rely on it.
4-Methyl-5-Bromoimidazole isn’t a household name, yet it holds a core spot in the toolkit of medicinal chemists and organic synthesis experts. Its chemical backbone—a bromo-substituted imidazole ring with a methyl group at the fourth position—gives it reactivity that’s especially tuned for modifying molecules at specific sites. Anyone who’s tried to substitute halogens in heterocycles knows the frustration when a compound’s selectivity limits get in the way. Here, the combination of methyl and bromine atoms brings versatility in coupling, alkylation, and further functionalization.
The model most labs source sits at a high purity, often above 98 percent. This matters in more than certification—impure chemicals introduce byproducts and can sidetrack sensitive syntheses. When I’ve worked on scale-up with lower-grade materials, yield losses and tough purification steps quickly pile on costs and delays. 4-Methyl-5-Bromoimidazole’s standard form appears as a solid that’s easily handled and weighed, which reduces hassle and spill risk, an important detail that matters if you’re making repeat batches.
One of the main draws of 4-Methyl-5-Bromoimidazole is its use as a building block for more complex pharmaceuticals and fine chemicals. The pharmaceutical field pushes for new scaffolds with activity against tough targets, and the presence of both a reactive bromo group and a modifiable methyl on the imidazole means chemists can adapt it for a broad spectrum of reactions. In my experience, having such flexibility often saves time, especially when synthesis teams face tight deadlines for lead optimization.
Researchers typically use it as a precursor when they need to append functional groups or construct new heterocyclic systems. There’s also a steady demand in agrochemical research for molecules that can be transformed into plant protection agents or growth regulators. The methyl-bromo pattern seems to offer a balance between reactivity and selectivity that’s hard to match with other imidazole derivatives.
In contrast to simpler compounds, this molecule allows for stepwise elaboration—first swapping out the bromine, then tuning the imidazole ring. Many of my colleagues value this two-stage control, since unplanned side reactions can derail months of work.
You might expect a methyl or bromo imidazole to offer similar performance, but as seen in comparison runs, not all reagents behave equally. Standard 5-bromoimidazole often brings more raw reactivity at the expense of selectivity, so you face a higher risk of forming unwanted byproducts. Toss a methyl group into the mix, and you get a shift not only in electronic properties but also in how the molecule fits with incoming reagents or metal catalysts.
As someone who spent late nights puzzling over purification columns, I learned to value any molecule that saves cleanup steps. 4-Methyl-5-Bromoimidazole usually leads to cleaner reactions, which translates to less time with silica gel and more trust in scale-up reproducibility. If you’re working with costly intermediates, that’s no small difference.
Not every lab has the luxury of in-house purification units. This makes starting with high-purity solid 4-Methyl-5-Bromoimidazole almost essential, especially in places with strict GMP compliance or quality control systems. I’ve seen colleagues pass over bulk lots with questionable traces of side products, knowing well the regulatory headaches that contaminated precursor stock can cause down the line.
Those who oversee inventory look for well-documented analytical data—clear NMR, HPLC, or GC readouts, with solid batch traceability. Suppliers with consistent specs earn trust through repeated orders, and a reliable supply chain ensures long-term project planning. Labs dealing with rapid development cycles can’t afford to gamble on chemicals with broad melting ranges or shifting purity. The model most trusted among researchers meets these daily demands.
In project teams I’ve joined, the real financial cost of a reagent goes beyond a number on an invoice. Unreliable precursors slow down method development, complicate analytics, and can force unplanned revalidation. With 4-Methyl-5-Bromoimidazole, its stable, predictable performance streamlines workflows for everything from small-batch discovery to pilot plant scale-ups.
Several times, I’ve heard formulators point out how a single batch failure due to subpar chemicals delays regulatory filings, impacting timelines for market entry. By using high-quality 4-Methyl-5-Bromoimidazole, teams keep project risks lower—not only in terms of end-product safety but also in budget and morale.
The main difference compared to other bromoimidazoles or methylimidazoles lies in its unique balance between reactivity and stability. The methyl group at position four blocks some undesirable side reactions, letting the bromine do its work in targeted substitution. Similar compounds without this methyl protection often spark more side reactions, which create headaches in trace analysis down the line.
Over years working with medicinal chemistry teams, I’ve seen that the subtle changes in substitution often dictate how many steps a project will need. This compound’s blueprint reduces the likelihood of branching off in unwanted synthetic routes—a huge plus for those who need pinpoint control. Generating analogues becomes less labor-intensive, which means parallel synthesis gains a boost.
Anyone managing QA or method validation knows the frustration that comes from unpredictable inputs. With 4-Methyl-5-Bromoimidazole, you get a well-characterized solid with limited sensitivity to common storage conditions—minus the strict controls necessary for more volatile reactants. This adds practical value for teams with diverse personnel, as it keeps standard operating procedures straightforward and cuts the risk of accidental spoilage.
In regulated environments, any short cut in documentation or impurity profile leads to audits and compliance issues. Choosing reagents that come with full analytical support and history means you avoid firefighting later. The most consistently supplied 4-Methyl-5-Bromoimidazole checks off these needs.
Handling specialty organics always brings questions about health and environmental footprint. While 4-Methyl-5-Bromoimidazole is classified as an irritant, it doesn’t present the acute hazards seen with some stronger brominated aromatics. In my experience, routine good practice—gloves, goggles, standard handling protocols—keeps risks minimal. Labs that maintain standard fume hood operations and keep solid storage dry rarely face incident reports when dealing with this compound.
Waste management is straightforward compared with more aggressively reactive halogenated imidazoles. Most facilities can dispose of residual material in line with existing solvent and organic waste streams, provided records are kept. This eases compliance with chemical disposal requirements and helps maintain an orderly working environment.
Securing a steady supply of specialty chemicals sometimes challenges even the best procurement teams. Sudden shortages or price surges hit especially hard for reagents not yet produced at major scale. Teams that rely on 4-Methyl-5-Bromoimidazole often benefit from establishing supply contracts with vendors known for transparency and traceability.
To dodge the problem of variable quality, project managers work closely with analytical teams at supplier labs to match specs batch-to-batch. From my perspective, open channels of communication between labs and suppliers ensure any drift in impurity profiles gets caught early. This approach saves wasted time troubleshooting downstream.
For groups pursuing green chemistry, future-focused solutions might involve developing recyclable methods for bromination or refining purification processes that cut down on solvent use. Technical advances here can reduce both cost and environmental impact.
While much attention to 4-Methyl-5-Bromoimidazole lands on the pharmaceutical and biotech worlds, its value stretches into materials science and custom manufacturing. Flexible intermediates such as this play a role in designing specialty dyes, diagnostic reagents, and electronic materials. I’ve seen research units adapt it for completely novel reaction systems, using its distinct substitution pattern to anchor catalysts or probe molecular interactions.
Today’s push toward faster and smarter R&D depends on molecules that accelerate workflow and open doors to new molecular frameworks. Those labs seeking to leap ahead of competitors often look for reagents that give them more room for creativity—without multiplying risk or overhead. From what I’ve seen, the right chemical tools make the difference between projects that stall in proof-of-concept and those that reach application. 4-Methyl-5-Bromoimidazole fits this niche well.
There is a temptation to save up-front costs by buying larger, generic lots from unknown sources, but the downstream expense from lost time, extra purification, or failed batches quickly outweighs those savings. I’ve watched newer colleagues learn this firsthand, facing lengthy troubleshooting when an unreliable source delivers product with unreported side impurities.
A track record of consistent supply, openness in documentation, and technical support makes a practical difference. Some of the best suppliers run lot-by-lot NMR and HPLC checks, report full impurity profiles, and respond quickly to questions. This responsiveness closes the gap between research lab and supplier, making the whole development cycle smoother.
As industries adapt to tighter regulatory scrutiny, detailed documentation and transparent supply chains move from nice-to-have to essential. Specialists working with 4-Methyl-5-Bromoimidazole now expect easy access to Certificates of Analysis, safety data, and even traceable production histories. Digital record-keeping helps speed up audits and reduces time spent chasing down missing paperwork.
This accountability links directly to broader demands for responsible sourcing. Researchers and managers want to know their chemicals come from facilities operating under rigorous safety, labor, and environmental rules. This shift doesn’t just protect lab workers; it supports sustainability goals and bolsters public trust in finished products built from specialty reagents.
While the fundamental chemistry of 4-Methyl-5-Bromoimidazole remains steady, there’s always room for improvement. Automation in synthesis and purification could help labs reduce manual handling errors and boost yields. Reducing the reliance on hazardous solvents or harsh reagents in its production offers a pathway toward greener chemistry.
If suppliers can produce this compound more cleanly, with tighter impurity control and less environmental impact, everyone benefits. Partnerships between manufacturers and research groups may lead to process tweaks that cut down waste or open new synthetic shortcuts. It’s a win for efficiency, safety, and the bottom line.
From my experience, working with 4-Methyl-5-Bromoimidazole streamlines projects that would otherwise bog down in reruns and purification bottlenecks. The solid form makes weighing and transfer simple, and feedback from process engineers reflects satisfaction with the consistency between batches.
On teams pursuing tough timelines or aiming for regulatory filings, the reduced batch-to-batch variables let everyone focus more on innovation and less on fixing avoidable errors. Having a reliable intermediate at the ready can spell the difference between weeks spent diagnosing process failures and quick, confident progression from concept to final product.
The mark of a good intermediate shows in how seldom it draws attention—no panicked troubleshooting, no last-minute substitutions in reaction schemes. For those building new molecules, every saved step and every mitigated risk carries weight, whether the application is in healthcare, agriculture, or advanced materials.
Looking ahead, continued access to well-documented and high-quality 4-Methyl-5-Bromoimidazole supports not only today’s projects but also the larger ecosystem of science and technology. Reagents that combine reliability with room for adaptation encourage exploration and invention—critical factors as fields evolve and push the boundaries of what’s possible. My own work affirms that the right chemicals aren’t simply commodities; they act as enablers of progress across many industries, underscoring the real, everyday value of thoughtful sourcing and attention to detail.